Dr. Nirmal Kaur
Address: 1 Ford Pace, Detroit, Michigan, 48202, United States, Wayne State University
About the Doctor
Dr. Nirmal Kaur-Gastroenterologist with clinical interests in inflammatory bowel disease, pouchitis.View Contact Details
Degree: State University of New York NY
Residency: University of Michigan, Internal Medicine, MI
- Dr. Nirmal Kaur currently works with Henry Ford Health System.
- Large Pericardial Angiosarcoma Encasing the Ostial Right Coronary Artery Requiring Percutaneous Coronary Intervention.
- Forme Fruste in Recurring Mid-Ventricular Variant of Takotsubo Cardiomyopathy.
- Ticagrelor-induced Angioedema After Percutaneous Coronary Intervention in a Patient with a History of Ischemic Stroke and Low Response to Clopidogrel: A Rare Dilemma.
- Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
- Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis.
- Private troubles to public issue: empowering communities to reduce alcohol-related harm in Sabah, Malaysia.
- Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
- Lumbar Plexopathy Secondary to Spontaneous Large Retroperitoneal Hematoma.
- Surveillance Evaluation of the National Cancer Registry in Sabah, Malaysia.
- Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients.
- Scope of shared decision making in patients with psychologic complaints.
- Regional pericardits: a mischievous masquerader.
- Evaluation of right ventricular function in Takotsubo cardiomyopathy.
- Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.
- Ergonomic implementation and work station design for quilt manufacturing unit.
- Intestinal dysbiosis in inflammatory bowel disease.
- Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases.
- Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.